Puma Biotechnology, Inc. (PBYI)
NASDAQ: PBYI · Real-Time Price · USD
2.925
-0.035 (-1.18%)
Apr 1, 2025, 3:47 PM EDT - Market open
Puma Biotechnology Revenue
In the year 2024, Puma Biotechnology had annual revenue of $230.47M, down -2.19%. Puma Biotechnology had revenue of $59.08M in the quarter ending December 31, 2024, a decrease of -18.15%.
Revenue (ttm)
$230.47M
Revenue Growth
-2.19%
P/S Ratio
0.62
Revenue / Employee
$1,339,930
Employees
172
Market Cap
145.11M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 230.47M | -5.17M | -2.19% |
Dec 31, 2023 | 235.64M | 7.61M | 3.34% |
Dec 31, 2022 | 228.03M | -25.12M | -9.92% |
Dec 31, 2021 | 253.16M | 28.05M | 12.46% |
Dec 31, 2020 | 225.11M | -47.15M | -17.32% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 400.28B |
Johnson & Johnson | 88.82B |
Merck & Co. | 64.17B |
AbbVie | 56.33B |
AstraZeneca | 54.07B |
Novartis AG | 51.72B |
Eli Lilly and Company | 45.04B |
Thermo Fisher Scientific | 42.88B |
PBYI News
- 1 day ago - Puma SE: Undervalued With Tailwinds Ahead - Seeking Alpha
- 6 days ago - Puma Biotechnology to Present Clinical Data on Neratinib at the AACR Annual Meeting 2025 - Business Wire
- 11 days ago - PUMA SE: This Is The Right Time To Buy - Seeking Alpha
- 26 days ago - Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 26 days ago - Puma Biotechnology to Present at Barclays Annual Global Healthcare Conference - Business Wire
- 4 weeks ago - Puma Biotechnology, Inc. (PBYI) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - Puma Biotechnology Reports Fourth Quarter and Full Year 2024 Financial Results - Business Wire
- 4 weeks ago - Puma Biotechnology to Present at TD Cowen's 45th Annual Health Care Conference - Business Wire